EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Deep Immune and RNA Profiling Revealed Distinct Circulating CD163+ Monocytes in Diabetes-Related Complications

Elisha Siwan, Jencia Wong, Belinda A Brooks, Diana Shinko, Callum J Baker iD, Nandan Deshpande, Susan V McLennan, Stephen M Twigg, Danqing Min

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms251810094 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Elisha Siwan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Greg Brown Diabetes and Endocrine Research Laboratory, Sydney Medical School (Central), Faculty of Medicine and Health, Charles Perkin Centre, The Un…. Hauptthemen laut MEDLINE: Antigens, CD, Monocytes, Receptors, Cell Surface, Antigens, Differentiation, Myelomonocytic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Diabetes Australia, Endocrinology Trust Fund at Royal Prince Alfred Hospital, Sydney, NSW, Australia, Diabetes Australia Research Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CD163, a scavenger receptor with anti-inflammatory function expressed exclusively on monocytes/macrophages, is dysregulated in cases of diabetes complications. This study aimed to characterize circulating CD163+ monocytes in the presence (D+Comps) or absence (D−Comps) of diabetes-related complications. RNA-sequencing and mass cytometry were conducted on CD163+ monocytes in adults with long-duration diabetes and D+Comps or D−Comps. Out of 10,868 differentially expressed genes identified between D+Comps and D−Comps, 885 were up-regulated and 190 were down-regulated with a ≥ 1.5-fold change. In D+Comps, ‘regulation of centrosome cycle’ genes were enriched 6.7-fold compared to the reference genome. MIR27A, MIR3648-1, and MIR23A, the most up-regulated and CD200R1, the most down-regulated gene, were detected in D+Comps from the list of 75 ‘genes of interest’. CD163+ monocytes in D+Comps had a low proportion of recruitment markers CCR5, CD11b, CD11c, CD31, and immune regulation markers CD39 and CD86. A gene–protein network identified down-regulated TLR4 and CD11b as ‘hub-nodes’. In conclusion, this study reports novel insights into CD163+ monocyte dysregulation in diabetes-related complications. Enriched centrosome cycle genes and up-regulated miRNAs linked to apoptosis, coupled with down-regulated monocyte activation, recruitment, and immune regulation, suggest functionally distinct CD163+ monocytes in cases of diabetes complications. Further investigation is needed to confirm their role in diabetes-related tissue damage.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antigens, CDMonocytesReceptors, Cell SurfaceAntigens, Differentiation, MyelomonocyticMicroRNAsHumansFemaleMaleMiddle AgedDiabetes ComplicationsOrexin ReceptorsGene Expression ProfilingAgedGene Expression RegulationAdultGene Regulatory NetworksBiomarkersCD163 Antigen

Stichwörter der Autor:innen

CD163complicationsdiabetes mellitusinflammationmonocytesscavenger receptor

Substanzen

Antigens, CDCD163 AntigenReceptors, Cell SurfaceAntigens, Differentiation, MyelomonocyticMicroRNAsOrexin ReceptorsCD200R1 protein, humanBiomarkers

Autor:innen und Institutionen

  • Greg Brown Diabetes and Endocrine Research Laboratory, Sydney Medical School (Central), Faculty of Medicine and Health, Charles Perkin Centre, The University of Sydney, Sydney, NSW 2006, Australia.
  • Department of Endocrinology, Royal Prince Alfred Hospital, Sydney, NSW 2050, Australia.
  • Sydney Cytometry, The University of Sydney, Sydney, NSW 2006, Australia.
  • Sydney Informatics Hub, The University of Sydney, Sydney, NSW 2006, Australia.
  • NSW Health Pathology, Sydney, NSW 2050, Australia.

ORCID-Profile: Callum J Baker

Förderung

  • Diabetes Australia
  • Endocrinology Trust Fund at Royal Prince Alfred Hospital, Sydney, NSW, Australia
  • Diabetes Australia Research Trust
  • Endocrinology Trust Fund at Royal Prince Alfred Hospital

Zitieren

APA

Siwan, E., Wong, J., Brooks, B. A., Shinko, D., Baker, C. J., Deshpande, N., McLennan, S. V., Twigg, S. M., & Min, D. (2024). Deep Immune and RNA Profiling Revealed Distinct Circulating CD163+ Monocytes in Diabetes-Related Complications. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms251810094

Vancouver

Siwan E, Wong J, Brooks BA, Shinko D, Baker CJ, Deshpande N, et al. Deep Immune and RNA Profiling Revealed Distinct Circulating CD163+ Monocytes in Diabetes-Related Complications. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms251810094

BibTeX
@article{Siwan2024,
  author = {Siwan, Elisha and Wong, Jencia and Brooks, Belinda A and Shinko, Diana and Baker, Callum J and Deshpande, Nandan and McLennan, Susan V and Twigg, Stephen M and Min, Danqing},
  title = {Deep Immune and RNA Profiling Revealed Distinct Circulating CD163+ Monocytes in Diabetes-Related Complications},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms251810094}
}
Kostenlos starten →